304 related articles for article (PubMed ID: 30447726)
1. Comorbidity of Borderline Personality Disorder: Current Status and Future Directions.
Shah R; Zanarini MC
Psychiatr Clin North Am; 2018 Dec; 41(4):583-593. PubMed ID: 30447726
[TBL] [Abstract][Full Text] [Related]
2. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.
Grant BF; Chou SP; Goldstein RB; Huang B; Stinson FS; Saha TD; Smith SM; Dawson DA; Pulay AJ; Pickering RP; Ruan WJ
J Clin Psychiatry; 2008 Apr; 69(4):533-45. PubMed ID: 18426259
[TBL] [Abstract][Full Text] [Related]
4. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission.
Zanarini MC; Frankenburg FR; Vujanovic AA; Hennen J; Reich DB; Silk KR
Acta Psychiatr Scand; 2004 Dec; 110(6):416-20. PubMed ID: 15521825
[TBL] [Abstract][Full Text] [Related]
5. Axis I comorbidity of borderline personality disorder.
Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
[TBL] [Abstract][Full Text] [Related]
6. Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence.
Lee HJ; Bagge CL; Schumacher JA; Coffey SF
Personal Disord; 2010 Oct; 1(4):239-49. PubMed ID: 21116439
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
[TBL] [Abstract][Full Text] [Related]
8. The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder.
Zanarini MC; Frankenburg FR; Hennen J; Silk KR
Am J Psychiatry; 2003 Feb; 160(2):274-83. PubMed ID: 12562573
[TBL] [Abstract][Full Text] [Related]
9. The course of anxiety disorders other than PTSD in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
Silverman MH; Frankenburg FR; Reich DB; Fitzmaurice G; Zanarini MC
J Pers Disord; 2012 Oct; 26(5):804-14. PubMed ID: 23013347
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning.
Tomko RL; Trull TJ; Wood PK; Sher KJ
J Pers Disord; 2014 Oct; 28(5):734-50. PubMed ID: 25248122
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity of borderline personality disorder with other personality disorders in psychiatric outpatients: how does it look at 2-year follow-up?
Nysæter TE; Nordahl HM
Nord J Psychiatry; 2012 Jun; 66(3):209-14. PubMed ID: 22017242
[TBL] [Abstract][Full Text] [Related]
12. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study.
Zanarini MC; Frankenburg FR; Weingeroff JL; Reich DB; Fitzmaurice GM; Weiss RD
Addiction; 2011 Feb; 106(2):342-8. PubMed ID: 21083831
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of borderline personality disorder: do the number of criteria met make a difference?
Asnaani A; Chelminski I; Young D; Zimmerman M
J Pers Disord; 2007 Dec; 21(6):615-25. PubMed ID: 18072863
[TBL] [Abstract][Full Text] [Related]
14. Clinical study of the relation of borderline personality disorder to Briquet's syndrome (hysteria), somatization disorder, antisocial personality disorder, and substance abuse disorders.
Hudziak JJ; Boffeli TJ; Kreisman JJ; Battaglia MM; Stanger C; Guze SB
Am J Psychiatry; 1996 Dec; 153(12):1598-606. PubMed ID: 8942457
[TBL] [Abstract][Full Text] [Related]
15. Axis I and II comorbidity and psychosocial functioning in female adolescents with borderline personality disorder.
Kaess M; von Ceumern-Lindenstjerna IA; Parzer P; Chanen A; Mundt C; Resch F; Brunner R
Psychopathology; 2013; 46(1):55-62. PubMed ID: 22890504
[TBL] [Abstract][Full Text] [Related]
16. Characterizing affective instability in borderline personality disorder.
Koenigsberg HW; Harvey PD; Mitropoulou V; Schmeidler J; New AS; Goodman M; Silverman JM; Serby M; Schopick F; Siever LJ
Am J Psychiatry; 2002 May; 159(5):784-8. PubMed ID: 11986132
[TBL] [Abstract][Full Text] [Related]
17. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity.
Links PS; Heslegrave R; van Reekum R
Can J Psychiatry; 1998 Apr; 43(3):265-70. PubMed ID: 9561315
[TBL] [Abstract][Full Text] [Related]
18. Borderline personality disorder and substance abuse: consequences of comorbidity.
Links PS; Heslegrave RJ; Mitton JE; van Reekum R; Patrick J
Can J Psychiatry; 1995 Feb; 40(1):9-14. PubMed ID: 7874683
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the 10-year course of borderline personality disorder.
Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
Am J Psychiatry; 2006 May; 163(5):827-32. PubMed ID: 16648323
[TBL] [Abstract][Full Text] [Related]
20. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
